REGINALD SEGAR: Open Payments
NPI 1720057417 · EUNICE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$77 in 4 payments from 3 companies in 2025. Trend: 2023 $250 · 2024 $152 · 2025 $77
Food & beverage: $77
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| ABBVIE INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: FARXIGA, QULIPTA, TRELEGY ELLIPTA, BREZTRI.
Industry payments across LA — which companies pay providers there.
